US2007135391A1PendingUtilityA1

Microbicidal compositions and their use

Assignee: BASF AGPriority: Nov 11, 2003Filed: Oct 2, 2004Published: Jun 14, 2007
Est. expiryNov 11, 2023(expired)· nominal 20-yr term from priority
A01N 59/16A01N 51/00A61L 2/16A61L 2/18
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition comprising a copper salt of N′-hydroxy-N-cyclohexyldiazenium oxide (CuHDO) and a diluent is useful for combating and/or killing bacteria, mould, yeast and algae in industrial materials and or industrial processes. In a preferred embodiment CuHDO is generated in-situ within the application or medium. The composition may additionally include at least one or certain other biocidal active components.

Claims

exact text as granted — not AI-modified
1 . Use, for combating and/or killing bacteria, mould, yeast, and algae in industrial materials and/or industrial processes of a composition comprising (A) a copper salt of N′-hydroxy-N-cyclohexyldiazenium oxide (CuHDO) and a diluent, wherein the composition has a pH of at least 4.  
   
   
       2 . Use according to  claim 1 , wherein the CuHDO is generated in-situ within the application or medium using a water-soluble salt of N′-hydroxy-N-cyclohexyldiazenium oxide and a Cu-containing salt.  
   
   
       3 . Use according to claims  1  or  2 , wherein the composition additionally comprises another microbicidally active component (B) selected from: alcohols, isothiazolones, activated halogen compounds, formaldehyde release compounds, phenolic compounds, aldehydes, acids and esters, biphenyls, urea derivatives, O-acetals, O-formals, N-acetals, N-formals, benzamidines, phthalimides, pyridine derivatives, quaternary ammonium and phosphonium compounds, amines, amphoteric compounds, dithiocarbamates, compounds containing active oxygen and mixtures of any of these.  
   
   
       4 . Use according to claims  1  or  2 , wherein the other active component (B) is selected from at least one of 2-bromo-2-nitropropane1,3-diol, 1,2-benzisothiazol-3(2H)-one, 1,3,5-tris-(2-hydroxyethyl)-1,3,5-hexahydrotriazine, 5chloro-2-methyl-2H-isothiazol-3-one, 2-methyl-2H-isothiazol-3-one, tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)-imidazo[4,5-d]imidazole-2,5(2H,3H)-dione, 1,3-dimethyl-5,5-dimethylhydantoin and a polyvinylamine, IPBC, terbutryn, ziram, zineb, dichlofluanid, trichlofuanid, folpet, metal dihexa-2,4-dienoate, tebuconazole, 3benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine-4-oxide, pyrithiones, thiram, cybutryne, MBT, carbendazim, diuron, chlorotoluron, fluorometuron, thiabendazole, metazachlor, CuSCN, or dicopper oxide.  
   
   
       5 . Use according to  claim 3  to  4 , wherein the respective amounts of the components (A) and (B) in the composition, by weight of the total amount of (A) and (B), are (A) 1 to 99 wt % and (B) 1 to 99 wt %.  
   
   
       6 . Use according to  claim 3  to  4  wherein the said respective amounts of (A) and (B) are (A) 40 to 60 wt % and (B) 40 to 60 wt %.  
   
   
       7 . Use according to any one of  claims 1  to  6 , in the form of a paste, emulsion or solution or suspension.  
   
   
       8 . Use according to any of  claims 1  to  7 , wherein the composition has a pH of at least 7.  
   
   
       9 . Use according to any of  claims 1  to  7 , wherein the composition has a pH of at least of from 8 to 12.

Join the waitlist — get patent alerts

Track US2007135391A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.